ClinicalTrials.Veeva

Find clinical trials for Lung Cancer in Rochester, MN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Non-Small-Cell Lung Carcinoma
Cancer
Carcinoma
Small Cell Lung Carcinoma
Squamous Cell Carcinoma of Head and Neck
Triple Negative Breast Cancer
Colorectal Cancer

Lung Cancer trials near Rochester, MN, USA:

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

This is a study of the efficacy, pharmacokinetics, and safety of DS-1062a in participants with advanced or metastatic non-small cell lung ca...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: DS-1062a

Phase 2

Daiichi Sankyo

Rochester, Minnesota, United States and 83 other locations

agent, in subjects undergoing surgery for proven or suspected cancer in the lung. Approximately 100 subjects will be enrolled to en...

Enrolling
Lung Cancer
Lung Metastases
Drug: VGT-309

Phase 2

Vergent Bioscience

Rochester, Minnesota, United States and 4 other locations

This study is designed to identify the target Non-Small Cell Lung Cancer (NSCLC) population(s) that overexpress c-Met (c-Met+) best...

Active, not recruiting
Non-small Cell Lung Cancer
Drug: Telisotuzumab vedotin

Phase 2

AbbVie
AbbVie

Rochester, Minnesota, United States and 252 other locations

combination with standard of care carboplatin and pemetrexed) in 21 day treatment cycle for participants with advanced non-small cell lung ...

Active, not recruiting
Non-Small-Cell Lung Cancer
Drug: Amivantamab
Drug: Pemetrexed

Phase 1

Janssen
Janssen

Rochester, Minnesota, United States and 72 other locations

A Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS muta...

Enrolling
Stage III Non-small Cell Lung Cancer
Stage III Pancreatic Cancer
Drug: BMF-219

Phase 1

Biomea Fusion

Rochester, Minnesota, United States and 22 other locations

doublet chemotherapy (PDCT) versus nivolumab in combination with PDCT in the first-line treatment of Stage IV or recurrent non-small cell lung...

Enrolling
NSCLC
Drug: Cisplatin
Drug: Nivolumab

Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Rochester, Minnesota, United States and 22 other locations

This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with adagrasib in patients with G12C Non-Small Cell Lung...

Enrolling
Metastatic Cancer
Advanced Cancer
Drug: avutometinib (VS-6766) and adagrasib

Phase 1, Phase 2

Verastem

Rochester, Minnesota, United States and 7 other locations

The purpose of this study is to evaluate BMS-986442 in combination with nivolumab (with or without chemotherapy) for its antitumor efficacy and benef...

Active, not recruiting
Non-small Cell Lung Cancer
Advanced Solid Tumors
Drug: Carboplatin
Biological: BMS-986442

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Rochester, Minnesota, United States and 33 other locations

Study 849-017 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemothera...

Enrolling
Metastatic Lung Cancer
Advanced NSCLC
Drug: Adagrasib oral dose of 400 mg twice daily tablets
Combination Product: Pembrolizumab

Phase 2

Mirati Therapeutics
Mirati Therapeutics

Rochester, Minnesota, United States and 50 other locations

This study will investigate the utility of biomarker-based triage for study participants with advanced non-small cell lung cancer (...

Active, not recruiting
Advanced Non-Small Cell Lung Cancer
Drug: Quavonlimab
Biological: Favezelimab

Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Rochester, Minnesota, United States and 80 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems